nicotinamide mononucleotide
Nicotinamide mononucleotide plays an important role in the energy production of human cells, but it will decrease with age.
Nicotinamide mononucleotide can inhibit the aging of nerves and blood vessels, regulate sleep, and delay aging; taking nicotinamide mononucleotide can effectively improve the weakness of cortical neurons, especially for reducing senile dementia and other conditions.
Functions and Applications
| Production name | nicotinamide mononucleotide | CAS No. | 1094-61-7 | ||
| Batch No. | NMN-191112 | Formula | C11H15N2O8P | ||
| MFG. Date | Nov. 12, 2019 | Quantity | 100 kg | ||
| Expiry Date | Nov. 11, 2021 | Report Date | Nov. 13,2019 | ||
| Inspection Standard | Enterprise Standard | ||||
| Test Items | Specifications | Results | |||
| Appearance | White to off white powder | White to off white powder | |||
| Appearance of solution | Clear and colorless | Clear and colorless | |||
| pH value of solution | 2~3 | 2.87 | |||
| Purity (HPLC) | Not less than 98.0% | 99.22% | |||
| Chlorides | Not more than 200 ppm | Complied | |||
| Sulfates | Not more than 300 ppm | Complied | |||
| Arsenic | Not more than 1 ppm | Complied | |||
| Heavy metals | Not more than 10 ppm | Complied | |||
| Loss on drying | Not more than 1% | 0.43% | |||
| Aerobic bacterial count | Maximum 3^104 CFU/g | <1000 CFU/g | |||
| Coliform bacteria | Maximum 0.92 MPN/g | <0.45 MPN/g | |||
| Molds and yeasts | Maximum 50 CFU/g | < 25 CFU/g | |||
| Staphylococcus aureus | Maximum 0/25 g | Complied | |||
| Conclusion: The product conforms to Enterprise Standard. | |||||
